Bio-Techne shares traded on Nasdaq, and TD Cowen reiterated a Buy rating with a $65 price target.

The entities involved

• Bio-Techne →

  company

  • Bio-Techne has entered a strategic partnership with Spear Bio to distribute its immunoassays, advancing therapeutic development.Sun 13:32
  • Trump pledged to unleash American oil and gas, involving MBX Biosciences, Inc.Sun 05:01
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36

Related events

• TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.Aug 18
• Jefferies Financial Group boosted its price target and gave a buy rating, while TD Cowen started coverage and issued a buy rating for Voyager Technologies, Inc.Jun 11
• TD Cowen increased its target price to $3.00, while Jefferies Financial Group was involved in a rating update for Plug Power, with MarketBeat aggregating the consensus data.Sep 4
• TD Cowen upgraded Cabaletta Bio shares to strong-buy, while Jefferies reissued a buy rating, and MarketBeat provided consensus data.Sep 14
• TD Cowen upgraded Crescent Biopharma shares to 'strong-buy', while Wedbush reiterated 'outperform', and a CEO sold shares under a 10b5-1 plan.Aug 27